跳至主要内容
临床试验/JPRN-UMIN000013464
JPRN-UMIN000013464已完成未知

oBservational clinical Research In chronic kidney disease patients with renal anemia :renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis stimulating agents,darbepoetiN alfa - BRIGHTE

iigata University Graduate School of Medical & Dental Sciences0 个研究点目标入组 2,000 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who are planning to start hemodialysis or renal transplantation within 24 weeks after enrolment; 2) Patients with a history of treatment with ESA except the ones who were treated temporarily more than 12 weeks before the enrollment; 3)Patients with malignant tumor, hematological disease, or hemorrhagic lesions; 4) Patients with hypersensitivity to ESA or any ingredient thereof; 5) Pregnant, lactating or possibly pregnant women or those who wish to be pregnant during the study period; 6) Patients who are participating in other clinical study; 7) Patients who are assessed as not eligible for the study by the investigator.

研究者

发起方
iigata University Graduate School of Medical & Dental Sciences

相似试验